The Swiss National COVID-19 Science Task Force was set up by the federal government to act as a scientific advisory body to the political authorities during the COVID-19 pandemic. Today, it has published fifteen Policy Briefs that focus on a wide range of the most pressing scientific issues for better understanding and managing the pandemic.
The COVID-19 pandemic is posing unprecedented challenges for Switzerland and most other countries in the world, in the medical field as in many other areas. The Swiss National COVID-19 Science Task Force both addresses specific questions from public authorities and identifies areas of research, which will help us to better understand and so combat COVID-19.
The Task Force has so far produced fifteen policy briefs that were submitted to the authorities in the recent days and are now being made available publicly in Switzerland and abroad. These address a wide range of topics such as the role of serological testing, the wearing of protective masks in various settings, the potential costs of contact tracing and the main ethical, legal and social benchmarks for strategies to come out of lockdown.
The Expert Groups of the Swiss National COVID-19 Science Task Force address urgent issues regarding the COVID-19 crisis in Policy Briefs, which are discussed and approved by the Advisory Panel and published on the internet. They reflect the thinking of the Taskforce on this topic at that time. If required, the policy briefs are updated in the light of new studies or other data.
The Science Task Force was appointed by the Federal Council Coronavirus Crisis Unit (KSBC) the Federal Office of Public Health (FOPH) and the State Secretariat for Education, Research and Innovation (SERI).
The Task Force comprises an advisory panel and ten topic-based expert groups made up of professors from a wide range of Swiss higher education institutions and other institutions. All Task Force members work for the body on a voluntary basis in addition to their regular jobs.